Your browser doesn't support javascript.
Delineating a potent antiviral activity of Cuphea ignea extract loaded nano-formulation against SARS-CoV-2: In silico and in vitro studies.
Mahmoud, Dina B; Ismail, Walaa M; Moatasim, Yassmin; Kutkat, Omnia; ElMeshad, Aliaa N; Ezzat, Shahira M; El Deeb, Kadriya S; El-Fishawy, Ahlam M; Gomaa, Mokhtar R; Kandeil, Ahmed; Al-Karmalawy, Ahmed A; Ali, Mohamed A; Mostafa, Ahmed.
  • Mahmoud DB; Department of Pharmaceutics, Egyptian Drug Authority, formerly known as National Organization for Drug Control and Research, Giza, Egypt.
  • Ismail WM; Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Kasr-El-Ainy Street, Cairo, 11562, Egypt.
  • Moatasim Y; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, Egypt.
  • Kutkat O; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, Egypt.
  • ElMeshad AN; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Kasr-El-Ainy Street, Cairo, 11562, Egypt.
  • Ezzat SM; Department of Pharmaceutics, Faculty of Pharmacy and Drug Technology, The Egyptian Chinese University, Gesr El Suez st, PO 11786, Cairo, Egypt.
  • El Deeb KS; Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Kasr-El-Ainy Street, Cairo, 11562, Egypt.
  • El-Fishawy AM; Department of Pharmacognosy, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Giza, 12451, Egypt.
  • Gomaa MR; Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Kasr-El-Ainy Street, Cairo, 11562, Egypt.
  • Kandeil A; Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Kasr-El-Ainy Street, Cairo, 11562, Egypt.
  • Al-Karmalawy AA; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, Egypt.
  • Ali MA; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, Egypt.
  • Mostafa A; Department of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta, 34518, Egypt.
J Drug Deliv Sci Technol ; 66: 102845, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1428141
ABSTRACT
The outbreak of coronavirus disease-2019, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a worldwide emerging crisis. Polyphenols are a class of herbal metabolites with a broad-spectrum antiviral activity. However, most polyphenols encounter limited efficacy due to their poor solubility and degradation in neutral and basic environments. Thus, the effectiveness of their pharmaceutical application is critically dependent on the delivery systems to overcome the aforementioned drawbacks. Herein, Polyphenols-rich Cuphea ignea extract was prepared and its constituents were identified and quantified. Molecular docking was conducted for 15 compounds in the extract against SARS-CoV-2 main protease, among which rutin, myricetin-3-O-rhamnoside and rosmarinic acid depicted the most promising antiviral activity. Further, a self-nanoemulsifying formulation, composed of 10% oleic acid, 40% tween 20 and propylene glycol 50%, was prepared to improve the solubility of the extract components and enable its concurrent delivery permitting combined potency. Upon dilution with aqueous phases, the formulation rapidly Formsnanoemulsion of good stability and excellent dissolution profile in acidic pH when compared to the crude extract. It inhibited SARS-CoV-2 completely in vitro at a concentration as low as 5.87 µg/mL presenting a promising antiviral remedy for SARS-CoV-2, which may be attributed to the possible synergism between the extract components.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Topics: Traditional medicine Language: English Journal: J Drug Deliv Sci Technol Year: 2021 Document Type: Article Affiliation country: J.jddst.2021.102845

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Topics: Traditional medicine Language: English Journal: J Drug Deliv Sci Technol Year: 2021 Document Type: Article Affiliation country: J.jddst.2021.102845